|Terrence L. Cascino, MD, FAAN
||Dr. Cascino has nothing to disclose.
|J. Helen Cross
||Patent applications are submitted for a C10 preparation Betasht, with UCL/Royal Holloway and Vitaflo. Research support from Vitaflo – clinical trial Betashot in epilepsy Chief Investigator UK GW Pharma Study and local PI, CBD in DRavt syndrome and Lennox Gastaut Syndrome PI Fenfluramine in Dravet syndrome All remuneration to the department Vitaflo – clinical trial Betashot in.
|Nancy J. Newman, MD, FAAN
||Dr. Newman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GenSight Biologics and Quark Pharmaceuticals. Dr. Newman has received research support from GenSight Biologics and Santhera Pharmaceuticals.
|Ronald C. Petersen, PhD, MD, FAAN
||Dr. Petersen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche, Inc., Merck, Inc., Biogen, Inc., Genentech, Inc.. Dr. Petersen has received royalty, license fees, or contractual rights payments from Oxford University Press.